Gallium Citrate Ga 67 vs Pembrolizumab

Gallium Citrate Ga 67 vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between Gallium Citrate Ga 67 and Pembrolizumab.

Mechanism of Action

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Pharmacokinetics

Half-life: Pembrolizumab — 26 days.

Chemical Properties

Type: Gallium Citrate Ga 67 — Small molecule; Pembrolizumab — Antibody.